Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 19/20 | 0.74 |
| ▸ | BRD4 | O60885 | 1/20 | 0.51 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14794917 | 0.86 | KCNK3 (0.73) | KCNK3BRD4CREBBP | |
| SCHEMBL14785369 | 0.85 | KCNK3 (0.83) | KCNK3BRD4CREBBP | |
| SCHEMBL10805998 | 0.85 | KCNK3 (0.81) | KCNK3BRD4CREBBP | |
| SCHEMBL14784572 | 0.85 | KCNK3 (0.66) | KCNK3 | |
| SCHEMBL14786414 | 0.85 | KCNK3 (1.00) | KCNK3BRD4CREBBP | |
| SCHEMBL14784517 | 0.85 | KCNK3 (1.00) | KCNK3 | |
| SCHEMBL14784540 | 0.84 | KCNK3 (0.69) | KCNK3BRD4CREBBP | |
| SCHEMBL14784796 | 0.83 | KCNK3 (0.70) | KCNK3BRD4CREBBP | |
| SCHEMBL14785044 | 0.83 | KCNK3 (0.83) | KCNK3BRD4CREBBP | |
| SCHEMBL14784582 | 0.82 | KCNK3 (0.78) | KCNK3BRD4CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013037914-A1 | SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM | SANOFI (FR) | 2013-03-21 | — | — | WO | claimed |
| WO-2013037914-A1 | SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM | SANOFI (FR) | 2013-03-21 | — | — | WO | disclosed |